DISCOUNT ZERTIFIKAT - BECTON DICKINSON AND CO. Stock

Certificat

DE000ME7TXM1

Real-time Bid/Ask 07:53:06 2024-06-05 am EDT
152.15 EUR / 153.62 EUR +0.50% Intraday chart for DISCOUNT ZERTIFIKAT - BECTON DICKINSON AND CO.
Current month-0.04%
1 month-0.46%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-04 152.1 +0.20%
24-06-03 151.8 -0.24%
24-05-31 152.2 -0.01%
24-05-30 152.2 -0.14%
24-05-29 152.4 +0.54%

Delayed Quote Börse Stuttgart

Last update June 04, 2024 at 02:50 pm EDT

More quotes

Static data

Product typeDiscount Certificates
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer Morgan Stanley
WKN ME7TXM
ISINDE000ME7TXM1
Date issued 2024-01-29
Maturity 2024-12-20 (198 Days)
Parity 1 : 1
Emission price 151.8
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 153.8
Lowest since issue 148.4
Spread 1.48
Spread %0.96%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
238.5 USD
Average target price
278.7 USD
Spread / Average Target
+16.85%
Consensus